Hubei Goto Biopharm Co Ltd. Stock Analysis 300966.SZ

Hubei Goto Biopharm Co., Ltd. engages in the research, development, production, and sale of steroidal drug raw materials. The company is headquartered in Xiangfan, Hubei. The company went IPO on 2021-04-09. The firm's main products include starting materials, intermediates and active pharmaceutical ingredients (APIs) required for steroid drug production. Regarding starting materials, the Company's main products currently include 4-androstenedione (4-AD), androstenedione (ADD), bacitracol (BA), and 9-hydroxyandrostenedione (9OH-AD). In pharmaceutical intermediates, the Company possesses intermediates for sex hormones, progestins, corticosteroids and other types of intermediates. In APIs, the Company's main products include multiple products in the sex hormone, progestin and non-hormonal series.